Dopamine Uses the DRD5-ARRB2-PP2A Signaling Axis to Block the TRAF6-Mediated NF-κB Pathway and Suppress Systemic Inflammation.

Journal: Molecular Cell

Published: 2020-01-29

DOI: 10.1016/j.molcel.2020.01.022

Affiliations: 8

Authors: 9

Go to article
Institutions Share
Key Laboratory of Immunological Environment and Disease, NJMU, China 0.22
Center for Global Health, NJMU, China 0.22
State Key Laboratory of Reproductive Medicine (SKLRM), NJMU, China 0.22
Department of Pharmacology, NJUCM, China 0.11
State Key Laboratory of Neuroscience, SIBS CAS, China 0.11
Department of Biology, NUI Maynooth, Ireland 0.04
Human Health Institute, NUI Maynooth, Ireland 0.04
Centre for Experimental Medicine (CEM), QUB, United Kingdom (UK) 0.04

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER